Hello, Fool! | Login | Signup | My Fool
Dec 4, 2008 7:52 PM ET | Feedback | Site Changes | Help
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.
View All Commentary (UTHR)
Recs
nysegal (68.16) Submitted: 8/05/08 2:24 AM : Start Price: $111.57 UTHR Score: -21.66
UTHR is a terrific growth stock; accellerating earnings -- 80% in 08 and 68% in 09; recently reported fantastic earnings above street estimates.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK